Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

被引:445
|
作者
Boonstra, Kirsten [1 ]
Beuers, Ulrich [1 ]
Ponsioen, Cyriel Y. [1 ]
机构
[1] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1100 DD Amsterdam, Netherlands
关键词
Primary sclerosing cholangitis; Primary biliary cirrhosis; Epidemiology; Incidence; Prevalence; POPULATION-BASED COHORT; URSODEOXYCHOLIC ACID; NATURAL-HISTORY; DEFINED POPULATION; CLINICAL-FEATURES; PREVALENCE; COMMUNITY; SWEDEN; CHOLANGIOGRAPHY; AUSTRALIA;
D O I
10.1016/j.jhep.2011.10.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Studies on the epidemiology of primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) show variable outcome. We aimed at systematically reviewing the incidence and prevalence rates, as well as geographical distribution and temporal trends of PSC and PBC. Data sources: A systematic search of literature was performed in Medline and EMBASE (search last conducted January 10th, 2011). Study selection: Population-based epidemiological studies reporting incidence and/or prevalence rates for PSC or PBC in a defined geographical area of at least 100,000 adult inhabitants were considered relevant. Data extraction: Study area, study period, number of patients, number of inhabitants, incidence per 100,000 inhabitants per year, prevalence per 100,000 inhabitants, method of case-finding, method of case-ascertainment, male/female ratio and in case of PSC, occurrence of inflammatory bowel diseases (IBD) were extracted from retrieved articles. Results: The literature search yielded 2286 abstracts of which 31 articles fulfilled all inclusion criteria. Studies varied in size from 10 to 770 patients in catchment areas from 100,312 to 19,230,000 inhabitants. The incidence and prevalence rates for PSC range from 0 to 1.3 per 100,000 inhabitants/year and 0-16.2 per 100,000 inhabitants, respectively. PBC incidence rates range from 0.33 to 5.8 per 100,000 inhabitants/year and prevalence rates range from 1.91 to 40.2 per 100,000 inhabitants; prevalence rates are increasing in time. Conclusions: Incidence and prevalence rates of both PSC and PBC vary widely and seem to be increasing. True population-based studies are scarce and therefore large population-based studies combining meticulous case-finding and case-ascertainment strategies are necessary. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1181 / 1188
页数:8
相关论文
共 50 条
  • [21] The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis
    Floreani, Annarosa
    Motta, Raffaella
    Cazzagon, Nora
    Franceschet, Irene
    Roncalli, Massimo
    Del Ross, Teresa
    Rosina, Floriano
    Lleo, Ana
    Mescoli, Claudia
    Colloredo, Guido
    Invernizzi, Pietro
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (05) : 432 - 435
  • [22] The New Epidemiology of Primary Biliary Cirrhosis
    Griffiths, Laura
    Dyson, Jessica K.
    Jones, David E. J.
    SEMINARS IN LIVER DISEASE, 2014, 34 (03) : 318 - 328
  • [23] Primary Biliary Cholangitis Epidemiology, Diagnosis, and Presentation
    Faisal, Muhammad Salman
    Gonzalez, Humberto C.
    Gordon, Stuart C.
    CLINICS IN LIVER DISEASE, 2024, 28 (01) : 63 - 77
  • [24] Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective
    Beery, Renee M. Marchioni
    Vaziri, Haleh
    Forouhar, Faripour
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (04) : 266 - 284
  • [25] The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
    Kazuhito Kawata
    Yoshimasa Kobayashi
    M. Eric Gershwin
    Christopher L. Bowlus
    Clinical Reviews in Allergy & Immunology, 2012, 43 : 230 - 241
  • [26] Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid.
    Lee Y.M.
    Kaplan M.M.
    Current Gastroenterology Reports, 1999, 1 (1) : 38 - 41
  • [27] Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis
    Christian Rust
    Ulrich Beuers
    Clinical Reviews in Allergy & Immunology, 2005, 28 : 135 - 145
  • [28] Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
    Sclair, Seth N.
    Little, Ester
    Levy, Cynthia
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2015, 6
  • [29] Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis
    Rust, C
    Beuers, U
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (02) : 135 - 145
  • [30] Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Cheung, Angela C.
    LaRusso, Nicholas F.
    Gores, Gregory J.
    Lazaridis, Konstantinos N.
    SEMINARS IN LIVER DISEASE, 2017, 37 (02) : 159 - 174